Aetiology - Endogenous factors and cancer
A1 – A10
- A1: Association of P-glycoprotein and Bcl-2 with multi-drug resistance in chronic lymphocytic leukaemia
- A2: The IGF system in prostate cancer aetiology: a systematic review and meta-analysis
- A3: Folate, polymorphisms in folate-metabolising genes, and colorectal adenomas: results from a population-based case-only study
- A4: Familial non-VHL Clear Cell (Conventional) Renal Cell Carcinoma: clinical features, segregation analysis and mutation analysis of FCLN
- A5: Molecular pathways involved in mediating effects of type 1 insulin-like growth factor receptor (IGF1R) signalling on sensitivity of melanoma cells to Temozolomide (TMZ)
- A6: Histological Expression and function of complement molecules in ovarian cancer
- A7: The development of HPV-related cervical cancer: The influence of NQO1 and p53 polymorphic variation
- A8: Disease associations of FGFR2, TNRC9 and MAP3K1 polymorphisms in breast cancer
- A9: Metabolite changes in the transition from pre-invasive to invasive cervical cancer using in vivo magnetic resonance spectroscopy
- A10: Cancer patients with VTE have a distinct thrombosis risk factor profile compared with cancer-free patients with VTE
